Proposed issue of securities
Update Summary
Entity name
For personal use only
EVE HEALTH GROUP LIMITED.
Announcement Type
Update to previous announcement
Date of this announcement
20/4/2022
Reason for update to a previous announcement
Updating for approval at GM.
Refer to next page for full details of the announcement
Proposed issue of securities
1 / 6
Proposed issue of securities
Part 1 - Entity and announcement details
1.1 Name of +Entity
EVE HEALTH GROUP LIMITED.
For personal use only
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type ABN
Registration Number 89106523611
1.3 ASX issuer code EVE
1.4 The announcement is
Update/amendment to previous announcement
1.4a Reason for update to a previous announcement Updating for approval at GM.
1.4b Date of previous announcement to this update 22/2/2022
1.5 Date of this announcement 20/4/2022
1.6 The Proposed issue is:
A placement or other type of issue
Proposed issue of securities
2 / 6
Proposed issue of securitiesPart 7 - Details of proposed placement or other issue
For personal use only
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis?
Yes
7A.1a Conditions
Approval/Condition +Security holder approval
Date for determination 20/4/2022
Is the date estimated or actual?
** Approval received/condition met?
Actual
Yes
Comments
Part 7B - Issue details
Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)?
New class
Details of +securities proposed to be issued
Will the proposed issue of this +security include an offer of attaching +securities?
No
ISIN Code (if Issuer is a foreign company and +securities are non CDIs)Have you received confirmation from Will the entity be seeking quotationASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1?
No
ASX +security code
New class-code to be confirmed
Unlisted option exercisable at $0.005
+Security type
Options
of the 'new' class of +securities on ASX?
No
+Security description
Proposed issue of securities
3 / 6
Proposed issue of securities
Number of +securities proposed to be issued
466,666,667
Offer price details
For personal use only
Are the +securities proposed to be issued being issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
Nil consideration. The attaching options are being offered on a one for one basis to subscribers of the Placement announced 22 February 2022.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
0.0000001
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Options details
+Security currency | Exercise price | Expiry date |
AUD - Australian Dollar | AUD 0.0050 | 31/3/2024 |
Details of the type of +security that will be issued if the option is exercised
Other
Description
Unlisted options with a two year life and a $0.005 exercise price
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement.
Part 7C - Timetable
7C.1 Proposed +issue date 21/4/2022
Proposed issue of securities
4 / 6
Proposed issue of securities
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?
Yes
For personal use only
7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1 20/4/2022
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?
No
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?
No
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow?
No
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue?
No
7E.2 Is the proposed issue to be underwritten?
No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue 6% fee paid to brokers to any placement funds raised.
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Attaching option issued with placement shares, being used to raise funds to extend probiotic product range and working capital.
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?
No
7F.2 Any other information the entity wishes to provide about the proposed issue
Proposed issue of securities
5 / 6
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
EVE Investments Ltd. published this content on 20 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2022 05:14:07 UTC.